MIRACL: fatal or nonfatal Stroke
0
0.5
1
1.5
2
0
4
8
12
16
Time since randomization (weeks)
Cumulative Incidence (%)
Relative risk = 0.50
p=0.045
Atorvastatin
Placebo
1.6%
0.8%
Global Beneficial effects of LLT
| Previous slide | Next slide | Back to first slide | View graphic version |